Combination therapy with long-acting beta-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects
- PMID: 20522683
- DOI: 10.1136/ebm1050
Combination therapy with long-acting beta-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects
Comment on
-
Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review.Chest. 2009 Oct;136(4):1029-1038. doi: 10.1378/chest.09-0821. Epub 2009 Jul 24. Chest. 2009. PMID: 19633090
Publication types
LinkOut - more resources
Full Text Sources